Peptide: MHC-based DNA vaccination strategy to activate natural killer cells by targeting killer cell immunoglobulin-like receptors (2021)
Attributed to:
Using MHC class I peptides to modulate NK cell activity, as a basis for immunotherapy
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/jitc-2020-001912
PubMed Identifier: 34016721
Publication URI: http://europepmc.org/abstract/MED/34016721
Type: Journal Article/Review
Parent Publication: Journal for ImmunoTherapy of Cancer
Issue: 5
ISSN: 2051-1426